GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.87 $1.65 Thursday, 18th Apr 2024 ADAP stock ended at $0.90. This is 8.98% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 13.44% from a day low at $0.87 to a day high of $0.99.
90 days $0.691 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
2022-02-07 $2.86 $3.14 $2.86 $3.07 854 500
2022-02-04 $2.69 $2.85 $2.66 $2.81 487 400
2022-02-03 $2.71 $2.83 $2.69 $2.71 412 200
2022-02-02 $2.98 $2.98 $2.77 $2.80 481 100
2022-02-01 $2.91 $3.03 $2.83 $2.98 701 100
2022-01-31 $2.70 $2.93 $2.69 $2.92 627 000
2022-01-28 $2.68 $2.71 $2.59 $2.68 925 000
2022-01-27 $2.77 $2.85 $2.70 $2.71 575 400
2022-01-26 $2.91 $3.02 $2.79 $2.82 686 600
2022-01-25 $2.85 $2.94 $2.80 $2.86 477 300
2022-01-24 $2.81 $2.95 $2.68 $2.93 898 200
2022-01-21 $2.96 $3.00 $2.85 $2.89 850 400
2022-01-20 $3.02 $3.13 $2.95 $2.95 1 112 500
2022-01-19 $3.07 $3.14 $3.00 $3.01 1 187 700
2022-01-18 $3.27 $3.27 $3.06 $3.06 714 300
2022-01-14 $3.35 $3.40 $3.16 $3.30 768 700
2022-01-13 $3.42 $3.53 $3.35 $3.36 524 800
2022-01-12 $3.62 $3.63 $3.40 $3.42 579 500
2022-01-11 $3.50 $3.68 $3.48 $3.58 634 100
2022-01-10 $3.50 $3.53 $3.35 $3.47 714 700
2022-01-07 $3.64 $3.67 $3.50 $3.51 494 000
2022-01-06 $3.57 $3.65 $3.41 $3.61 755 000
2022-01-05 $3.81 $3.89 $3.56 $3.58 661 500
2022-01-04 $4.08 $4.12 $3.81 $3.84 605 844
2022-01-03 $3.84 $4.10 $3.77 $4.06 499 390
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT